inclusion criteria: documented covid-19 diagnosis (sars-cov-2 positivity as assessed by pcr) ≤3 days of symptom appearance, with a ct<25. symptoms related to day 1 ≤ 5 days. participant presents at least one of the following acute covid-19 symptoms: nasal congestion or runny nose, sore throat, headache, myalgia, dry/productive cough, fever, chills, abdominal symptoms (nausea, vomiting, diarrhea, abdominal pain), fatigue, chest pain, palpitations, and shortness of breath. participant is aged ≥ 16 years of age. participant has provided an appropriate signed informed consent.

inclusion criteria: documented covid-19 diagnosis (sars-cov-2 positivity as assessed by pcr) ≤3 days of symptom appearance, with a ct<25. symptoms related to day 1 ≤ 5 days. participant presents at least one of the following acute covid-19 symptoms: nasal congestion or runny nose, sore throat, headache, myalgia, dry/productive cough, fever, chills, abdominal symptoms (nausea, vomiting, diarrhea, abdominal pain), fatigue, chest pain, palpitations, and shortness of breath. participant is aged ≥ 16 years of age. participant has provided an appropriate signed informed consent.